A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice

Moustafa Mahmoud Hamdy, Takayoshi Mamiya, Yukihiro Noda, Merfat Sayed, Abdel Azim Assi, Adel Gomaa, Kiyofumi Yamada, Toshitaka Nabeshima

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We investigated the effect of rolipram, a selective phosphodiesterase IV inhibitor, on morphine dependence in mice. The withdrawal manifestations were significantly reduced in mice that were treated with rolipram in combination with morphine repeatedly, compared to the mice treated with morphine and saline. Immunohistochemical study of c-Fos protein revealed a significant increase in the protein expression, 1 h after naloxone induced withdrawal manifestations. A combination of rolipram and morphine treatment for 5 days prevented the increase of c-Fos protein expression. Acute rolipram treatment prior to the naloxone challenge had no effect. Repeated treatment with rolipram itself had no effect either on behavior, or on c-Fos protein expression. These results suggest that chronic rolipram treatment in combination with morphine in mice will abolish the development of morphine dependence and the expression of c-Fos protein induced by naloxone challenge.

Original languageEnglish
Pages (from-to)85-93
Number of pages9
JournalBehavioural Brain Research
Volume118
Issue number1
DOIs
Publication statusPublished - 08-01-2001

Fingerprint

Type 4 Cyclic Nucleotide Phosphodiesterase
Rolipram
Proto-Oncogene Proteins c-fos
Phosphodiesterase Inhibitors
Morphine
Naloxone
Morphine Dependence

All Science Journal Classification (ASJC) codes

  • Behavioral Neuroscience

Cite this

Hamdy, Moustafa Mahmoud ; Mamiya, Takayoshi ; Noda, Yukihiro ; Sayed, Merfat ; Assi, Abdel Azim ; Gomaa, Adel ; Yamada, Kiyofumi ; Nabeshima, Toshitaka. / A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. In: Behavioural Brain Research. 2001 ; Vol. 118, No. 1. pp. 85-93.
@article{392dfcded3684f149a2d6e795ff1d421,
title = "A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice",
abstract = "We investigated the effect of rolipram, a selective phosphodiesterase IV inhibitor, on morphine dependence in mice. The withdrawal manifestations were significantly reduced in mice that were treated with rolipram in combination with morphine repeatedly, compared to the mice treated with morphine and saline. Immunohistochemical study of c-Fos protein revealed a significant increase in the protein expression, 1 h after naloxone induced withdrawal manifestations. A combination of rolipram and morphine treatment for 5 days prevented the increase of c-Fos protein expression. Acute rolipram treatment prior to the naloxone challenge had no effect. Repeated treatment with rolipram itself had no effect either on behavior, or on c-Fos protein expression. These results suggest that chronic rolipram treatment in combination with morphine in mice will abolish the development of morphine dependence and the expression of c-Fos protein induced by naloxone challenge.",
author = "Hamdy, {Moustafa Mahmoud} and Takayoshi Mamiya and Yukihiro Noda and Merfat Sayed and Assi, {Abdel Azim} and Adel Gomaa and Kiyofumi Yamada and Toshitaka Nabeshima",
year = "2001",
month = "1",
day = "8",
doi = "10.1016/S0166-4328(00)00315-6",
language = "English",
volume = "118",
pages = "85--93",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1",

}

A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. / Hamdy, Moustafa Mahmoud; Mamiya, Takayoshi; Noda, Yukihiro; Sayed, Merfat; Assi, Abdel Azim; Gomaa, Adel; Yamada, Kiyofumi; Nabeshima, Toshitaka.

In: Behavioural Brain Research, Vol. 118, No. 1, 08.01.2001, p. 85-93.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice

AU - Hamdy, Moustafa Mahmoud

AU - Mamiya, Takayoshi

AU - Noda, Yukihiro

AU - Sayed, Merfat

AU - Assi, Abdel Azim

AU - Gomaa, Adel

AU - Yamada, Kiyofumi

AU - Nabeshima, Toshitaka

PY - 2001/1/8

Y1 - 2001/1/8

N2 - We investigated the effect of rolipram, a selective phosphodiesterase IV inhibitor, on morphine dependence in mice. The withdrawal manifestations were significantly reduced in mice that were treated with rolipram in combination with morphine repeatedly, compared to the mice treated with morphine and saline. Immunohistochemical study of c-Fos protein revealed a significant increase in the protein expression, 1 h after naloxone induced withdrawal manifestations. A combination of rolipram and morphine treatment for 5 days prevented the increase of c-Fos protein expression. Acute rolipram treatment prior to the naloxone challenge had no effect. Repeated treatment with rolipram itself had no effect either on behavior, or on c-Fos protein expression. These results suggest that chronic rolipram treatment in combination with morphine in mice will abolish the development of morphine dependence and the expression of c-Fos protein induced by naloxone challenge.

AB - We investigated the effect of rolipram, a selective phosphodiesterase IV inhibitor, on morphine dependence in mice. The withdrawal manifestations were significantly reduced in mice that were treated with rolipram in combination with morphine repeatedly, compared to the mice treated with morphine and saline. Immunohistochemical study of c-Fos protein revealed a significant increase in the protein expression, 1 h after naloxone induced withdrawal manifestations. A combination of rolipram and morphine treatment for 5 days prevented the increase of c-Fos protein expression. Acute rolipram treatment prior to the naloxone challenge had no effect. Repeated treatment with rolipram itself had no effect either on behavior, or on c-Fos protein expression. These results suggest that chronic rolipram treatment in combination with morphine in mice will abolish the development of morphine dependence and the expression of c-Fos protein induced by naloxone challenge.

UR - http://www.scopus.com/inward/record.url?scp=0035825277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035825277&partnerID=8YFLogxK

U2 - 10.1016/S0166-4328(00)00315-6

DO - 10.1016/S0166-4328(00)00315-6

M3 - Article

C2 - 11163637

AN - SCOPUS:0035825277

VL - 118

SP - 85

EP - 93

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1

ER -